// App-Quantinova.ai

21603 : Evolocumab and Outcomes in Patients With Peripheral Artery Disease

Researchers

Presenter

  • Marc P Bonaca

Principal Investigators

  • Patrice Nault

  • Robert P Giugliano

  • Anthony C Keech

  • Armando Lira Pineda

  • Estella Kanevsky

  • Sabina A Murphy

  • J. Wouter Jukema

  • Basil S Lewis

  • Lale Tokgozoglu

  • Ransi Somaratne

  • Peter S Server

  • Terje R Pedersen

  • Marc S Sabatine

Medical Centers

  • Vascular medicine, Cardiology, Brigham & Womens Hosp, Boston, MA

  • Vascular Surgery, McGill Univ, Montreal, Canada

  • Cardiovascular Medicine, Brigham & Womens Hosp, Boston, MA

  • Cardiovascular Medicine, Sydney Med Sch, Sydney, Australia

  • Clinical Rsch, Amgen, Thousand Oaks, CA

  • Cardiovascular Medicine, Leiden Univ Med Cntr, Leiden, Netherlands

  • Cardiovascular Medicine, Lady Davis Carmel Med Cntr, Haifa, Israel

  • Cardiovascular Medicine, Hacettepe Univ, Ankara, Turkey

  • Cardiovascular Rsch, Amgen, Thousand Oaks, CA

  • Cardiovascular Medicine, Imperial College London, London, United Kingdom

  • Cardiovascular Medicine, Oslo Univ Hosp, Oslo, Norway

Locations

  • United States

  • Canada

  • Australia

  • Netherlands

  • Israel

  • Turkey

  • United Kingdom

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Protein Tyrosine Phosphatase, Non-Receptor Type 22

  • Apoptotic body index

Drug/Treatment

  • Evolocumab

  • Desirudin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved